ASX:ACL Australian Clinical Labs (ACL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Australian Clinical Labs Stock (ASX:ACL) 30 days 90 days 365 days Advanced Chart Get ACL alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket Capitalization$728.27 millionP/E Ratio30.38Dividend Yield3.28%Price TargetN/AConsensus RatingN/A Company OverviewAustralian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.Read More… Receive ACL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address ACL Stock News HeadlinesHas Australian Clinical Labs Limited's (ASX:ACL) Impressive Stock Performance Got Anything to Do With Its Fundamentals?February 2, 2025 | finance.yahoo.comRBC Capital Remains a Buy on Australian Clinical Labs Ltd (ACL)January 31, 2025 | markets.businessinsider.comWarning: Elon’s $20k Robot Might Replace Your NannyTesla’s Robot Revolution Has Begun It’s official… Tesla’s robot revolution is underway… By the end of this year, Tesla plans to produce 600 new “Tesla Bots” per week… Tech insiders believe this could be the company’s next core driver of explosive growth. Some even believe it could be the catalyst that would push shares above the $1,000 mark. That’s essentially a 100% increase from today’s price…February 23, 2025 | WealthPress (Ad)Citi Reaffirms Their Buy Rating on Australian Clinical Labs Ltd (ACL)January 17, 2025 | markets.businessinsider.comAn Intrinsic Calculation For Australian Clinical Labs Limited (ASX:ACL) Suggests It's 40% UndervaluedDecember 8, 2024 | ca.finance.yahoo.comAustralian Clinical Labs Issues New SecuritiesDecember 2, 2024 | tipranks.comMelanoma blood test could detect skin cancer before it's visible to naked eyeNovember 30, 2024 | msn.comAustralian Clinical Labs Gains New Substantial InvestorNovember 29, 2024 | markets.businessinsider.comSee More Headlines ACL Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Australian Clinical Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Clinical Labs investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and Coles Group (COL). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:ACL CUSIPN/A CIKN/A Webwww.clinicallabs.com.au Phone61 3 9538 6777FaxN/AEmployees5,115Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.12 Trailing P/E Ratio30.38 Forward P/E RatioN/A P/E Growth-0.36Net Income$23.93 million Net Margins3.45% Pretax MarginN/A Return on Equity13.98% Return on Assets6.67% Debt Debt-to-Equity Ratio174.00 Current Ratio0.64 Quick Ratio0.53 Sales & Book Value Annual Sales$696.37 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.89 per share Price / BookN/AMiscellaneous Outstanding Shares201,830,000Free FloatN/AMarket Cap$728.27 million OptionableNot Optionable Beta1.18 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (ASX:ACL) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Australian Clinical Labs Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Australian Clinical Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
